Patents by Inventor Rampurna P. Gullapalli

Rampurna P. Gullapalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ABUSE RESISTANT OPIOID CONTAINING TRANSDERMAL SYSTEMS
    Publication number: 20140199383
    Abstract: The present invention relates to transdermal dosage form (FIGS. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIGS. 1-3) releases the inactivating agent upon disruption of the dosage form (FIGS. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIGS. 1-3).
    Type: Application
    Filed: January 21, 2014
    Publication date: July 17, 2014
    Applicant: PURDUE PHARMA L.P.
    Inventors: Lino Tavares, Bruce E. Reidenberg, Richard S. Sackler, Curtis Wright, Mark A. Alfonso, Benjamin Oshlack, James P. Cassidy, Anthony E. Carpanzano, Rampurna P. Gullapalli, Ihor Shevchuk
  • Methods of preparing progesterone pharmaceutical compositions
    Publication number: 20130122051
    Abstract: The invention provides a method of preparing a pharmaceutical composition comprising: (a) combining progesterone particles with a liquid carrier to provide a mixture; (b) wet-milling the mixture to provide a wet-milled progesterone composition; and (c) processing the wet-milled progesterone composition to provide a pharmaceutical composition. Pharmaceutical compositions prepared by the method are also provided.
    Type: Application
    Filed: May 25, 2012
    Publication date: May 16, 2013
    Applicant: PHARMACEUTICS INTERNATIONAL, INC.
    Inventors: Syed E. Abidi, Eric R. Coutinho, Sridhar Gumudavelli, Swati Agrawal, Rampurna P. Gullapalli
  • ?-carboline pharmaceutical compositions
    Patent number: 6841167
    Abstract: A soft capsule containing a solution or suspension of a PDE5 inhibitor, and use of the capsule in treating sexual dysfunction.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: January 11, 2005
    Assignee: Lilly Icos LLC.
    Inventors: Neil R. Anderson, Rampurna P. Gullapalli
  • Abuse resistant opioid containing transdermal systems
    Publication number: 20040241218
    Abstract: The present invention relates to transdermal dosage form (FIG. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIG. 1-3) releases the inactivating agent upon disruption of the dosage form (FIG. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIG. 1-3).
    Type: Application
    Filed: November 20, 2003
    Publication date: December 2, 2004
    Inventors: Lino Tavares, Bruce E Reidenberg, Richard S Sackler, Curtis Wright, Mark A Alfonso, Benjamin Oshlack, James P Cassidy, Anthony E Carpanzano, Rampurna P Gullapalli, Ihor Shevchuk